Exelixis, Inc. (NASDAQ:EXEL)
| CAPS Rating |
|
|---|---|
| Open | $5.66 |
| Previous Close | $5.67 |
| Daily Range | $5.60 - $6.27 |
| 52-Week Range | $3.94 - $12.82 |
| Market Cap | $791.90M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 10,414,995 |
| Average Daily Volume | 0 |
EXEL
VS S&P 500 (SPY)
How do you think EXEL will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
EXEL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
EXEL News and Commentary
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- When Passing Your Clinical Trial Isn't Enough – The Motley Fool
- Can Amgen Convince Docs to Recommend Approval? – The Motley Fool
- FDA Approval Isn't Enough – The Motley Fool
- Make Money in Dynamic Biotech Stocks the Easy Way – The Motley Fool
- The Magic Formula for Biotech – The Motley Fool
- 4-Star Stocks Poised to Pop: Exelixis – The Motley Fool
- 5 Reasons to Worry About 2012 – The Motley Fool
- JPMorgan Confab Kicks Off Biotech 2012 – Minyanville
- Is Exelixis' Growth for Real? – The Motley Fool
- Exelixis: 1 to Watch for 2012 – The Motley Fool
- What to Look For From Keryx and Aeterna Zentaris in 2012 – The Motley Fool
- Biotech Post-Holiday Regifting – The Motley Fool
- Exelixis 2011: Not What the Doctor Ordered – The Motley Fool
- The Biotech Garage Sale Continues – The Motley Fool
- 3 Biotech Stocks That Had a Bad 2011 – The Motley Fool
- A Biotech Garage Sale – The Motley Fool
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- Exelixis Licenses PI3K-Delta Inhibitor R&D Program To Merck – SmartMoney
- Making Cents in Penny Stocks – The Motley Fool
RSS Headlines
Fool UK
